Towards designing a synthetic antituberculosis vaccine : The Rv3587c peptide inhibits mycobacterial entry to host cells

Mycobacterium tuberculosis is considered one of the most successful pathogens in the history of mankind, having caused 1.7 million deaths in 2016. The amount of resistant and extensively resistant strains has increased; BCG has been the only vaccine to be produced in more than 100 years though it is...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2018
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/19225
Acceso en línea:
http://repository.urosario.edu.co/handle/10336/19225
Palabra clave:
Bcg Vaccine
Membrane Protein
Peptide 39265
Peptide 39266
Unclassified Drug
Antibody Detection
Bioinformatics
Circular Dichroism
Controlled Study
Drug Design
Host Pathogen Interaction
Human
Latent Tuberculosis
Lung Alveolus Epithelium Cell
Macrophage
Methodology
Monocyte Derived Macrophage
Mycobacterium
Mycobacterium Tuberculosis
Mycobacterium Tuberculosis H37Rv
Nonhuman
Promoter Region
Protein Binding
Protein Secondary Structure
Protein Structure
Tuberculosis
Vacuna BCG
Proteínas de membrana
Péptido 39 265
39266 péptido
Enfermedades
Article
Mycobacterium tuberculosis
Antígenos bacterianos
Rights
License
Abierto (Texto Completo)